Home
Conditions
Carcinogenesis

Clinical trial condition

Carcinogenesis

Explore clinical trials studying Carcinogenesis. Study availability and eligibility vary by location and protocol.

270 public trials 12 recruiting studies

Refine in advanced search Browse all conditions

Carcinogenesis trial results

Completed

Decitabine in Treating Patients With Melanoma or Other Advanced Cancer

NCT00002980

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations: Beckman Research Institute, City of Hope Duarte, California, United States

USC/Norris Comprehensive Cancer Center Los Angeles, California, United States

Los Angeles County-University of Southern California Medical Center Los Angeles, California, United States

University of California Davis Cancer Center Sacramento, California, United States

View Trial Details

Completed

Tipifarnib in Treating Patients With Advanced Hematologic Cancer

NCT00005967

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +68 more
Locations: University of Chicago Cancer Research Center Chicago, Illinois, United States

View Trial Details

Completed

XK469R in Treating Patients With Refractory Hematologic Cancer

NCT00095797

Conditions: Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), +66 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia

NCT00003997

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +22 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction

NCT00025415

Conditions: AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, Accelerated Phase Chronic Myelogenous Leukemia, +170 more
Locations: University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Dasatinib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate

NCT00316953

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Blast Crisis, Blastic Phase Chronic Myelogenous Leukemia, +29 more
Locations: Children's Oncology Group Arcadia, California, United States

View Trial Details

Completed

Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer

NCT00003451

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations: Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States

View Trial Details

Completed

STI571 Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia

NCT00015834

Conditions: Blast Crisis, Blastic Phase Chronic Myelogenous Leukemia, Bone Marrow Diseases, +17 more
Locations: University of California at Los Angeles (UCLA ) Los Angeles, California, United States

View Trial Details

Completed

3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies

NCT00077181

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +35 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Completed

Imatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous Leukemia

NCT00054431

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Blast Crisis, Blastic Phase Chronic Myelogenous Leukemia, +20 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Carcinogenesis

Carcinogenesis trial results

Related conditions